58 completed, 16 unknown, 11 terminated, 5 recruiting. 42 Phase 3, 31 Phase 2, 18 Not applicable, 11 Phase 1, 7 Phase 4.
Follow Dehydroepiandrosterone: new trials by email Literature Review of Dehydroepiandrosterone trials Research Report on Dehydroepiandrosterone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) Slow Release DHEA, Placebo - Asthma | Phase 2 | Not yet recruiting | Indiana University | 30 | 2027-01-01 | 2026-02-27 |
| Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial Pregnenolone, DHEA, Placebo - Chronic Low Back Pain | Phase 2 | Not yet recruiting | VA Office of Research and Development | 108 | 2026-12-01 | 2026-09-08 |
| Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression. Dehydroepiandrosterone (DHEA), Placebo - Treatment Resistant Depression (TRD) | Phase 3 | Recruiting | Charite University, Berlin, Germany | 320 | 2026-06-22 | 2026-09-28 |
| Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer Biospecimen Collection, Prasterone, Survey Administration - Anal Carcinoma, Cervical Carcinoma | Phase 2 | Recruiting | Ohio State University Comprehensive Cancer Center | 25 | 2026-03-12 | 2026-04-21 |
| Growth Hormone and Dehydroepiandrosterone Role in Vitro Fertilization Somatropin (4IU for 1 month) plus, folic acid 400 mcg per day., DHEA plus folic acid 400mcg per day, control group - Infertility, Infertility (IVF Patients) | Phase 2 / Phase 3 | Recruiting | Beni-Suef University | 165 | 2025-10-10 | 2026-01-07 |
| A Randomized Controlled Trial of Combined Bu Shen Yi Qi Decoction and Dehydroepiandrosterone (DHEA) for the Treatment of Ovarian Function Decline Bushen formula combined with dehydroepiandrosterone, Placebo combined with dehydroepiandrosterone - Diminished Ovarian Reserve | Phase 1 / Phase 2 | Recruiting | Jiangxi University of Traditional Chinese Medicine | 74 | 2025-09-01 | 2026-06-03 |
| Effect of Intravaginal Prasterone on Symptoms of Genitourinary Syndrome of Menopause (GSM) in Women in Menopause With Previous Breast Cancer Prasterone (DHEA) - Women With Breast Cancer | Phase 3 | Not yet recruiting | European Institute of Oncology | 95 | 2024-12-01 | 2024-11-19 |
| The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders myo-inositol, Somatropin, Dehydroepiandrosterone - Poor Responders | Phase 2 / Phase 3 | Unknown | Beni-Suef University | 300 | 2023-07-30 | 2023-07-18 |
| Vaginal Prasterone Versus Estriol in Women With Pelvic Floor Disorders Prasterone (DHEA), Estriol - Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI) | Not applicable | Completed | Poznan University of Medical Sciences | 74 | 2022-10-01 | 2026-10-08 |
| Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS) Dehydroepiandrosterone (DHEA), 11-ketoandrostenedione (11KA4) - Polycystic Ovary Syndrome, Insulin Resistance | Not applicable | Unknown | Royal College of Surgeons, Ireland | 20 | 2022-08-19 | 2023-07-25 |
| GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy. Estrogen, dehydroepiandrosterone, Estrogen + probiotics - Vulvovaginal Atrophy, Breast Cancer | Phase 4 | Completed | University Hospital, Ghent | 31 | 2022-03-21 | 2026-08-13 |
| Effects of DHEA and Exercise on Bone Marrow Fat in Postmenopausal Women Exercise, DHEA - Low Bone Density, Osteoporosis | Not applicable | Completed | University of Colorado, Denver | 41 | 2022-03-11 | 2024-12-10 |
| Effectiveness of Adjuvant Supplements Prior to in IVF DHEA, DHEA+CoQ10+Tocotrienol - Dietary Supplements | Not applicable | Completed | Kaohsiung Veterans General Hospital. | 70 | 2022-03-02 | 2024-08-02 |
| Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome oral androgen challenge with dehydroepiandrosterone (DHEA) - Polycystic Ovary Syndrome | Not applicable | Unknown | University of Birmingham | 100 | 2021-10-10 | 2022-11-02 |
| A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy intravaginal prasterone, Placebo ovules - Postmenopausal Vulvovaginal Atrophy | Phase 3 | Completed | Lee's Pharmaceutical Limited | 417 | 2021-09-13 | 2024-10-18 |
| Vaginal Dehydroepiandrosterone (DHEA) in Postmenopausal Breast Cancer Survivors on Aromatase Inhibitors Vaginal Dehydroepiandrosterone, Vaginal Polycarbophil Moisturizer - Vaginal Atrophy, Postmenopausal Symptoms | Phase 2 | Terminated | University of Arkansas | 8 | 2021-06-07 | 2024-11-27 |
| Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain Prasterone 6.5 MG, Placebo - Vulvovaginal Atrophy | Phase 3 | Unknown | Dr. Santiago Palacios | 50 | 2020-12-22 | 2021-06-02 |
| Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors Prasterone (DHEA), Micronized - Vulvar Atrophy, Breast Cancer | Phase 4 | Completed | Hospital Clinic of Barcelona | 10 | 2020-09-01 | 2022-02-22 |
| Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women Prasterone, Placebo - Recurrent Urinary Tract Infection, Postmenopause | Phase 3 | Withdrawn | Olivia Cardenas-Trowers, M.D. | 2020-05-01 | 2021-06-30 | |
| Neurosteroids in PTSD - Biomarkers to Therapeutics DHEA - Posttraumatic Stress Disorder | Phase 2 | Terminated | VA Office of Research and Development | 5 | 2019-07-08 | 2023-05-06 |
Showing 20 of 100. Sign in to see all of them.
Infertility (14) · Breast Neoplasms (7) · Lupus Erythematosus, Systemic (7) · Atrophic Vaginitis (6) · Primary Ovarian Insufficiency (5) · Rare Diseases (4) · Arthritis (3) · Bone Diseases, Metabolic (3) · Communicable Diseases (3) · Connective Tissue Diseases (3) · Dyspareunia (3) · Immune System Diseases (3) · Infertility, Female (3) · Insulin Resistance (3) · Osteoporosis (3)
EndoCeutics Inc. (9) · Cairo University (4) · National Center for Research Resources (NCRR) (4) · CHU de Quebec-Universite Laval (3) · Center for Human Reproduction (3) · Mayo Clinic (3) · Beni-Suef University (2) · Genelabs Technologies (2) · Kaohsiung Veterans General Hospital. (2) · Laboratorios Andromaco S.A. (2) · National Institute on Aging (NIA) (2) · ShangHai Ji Ai Genetics & IVF Institute (2) · University of Colorado, Denver (2) · University of Maryland, Baltimore (2) · VA Office of Research and Development (2)
United States (45) · Canada (12) · China (6) · Egypt (6) · Germany (3) · Taiwan (3) · United Kingdom (3) · Chile (2) · Italy (2) · Mexico (2) · Spain (2) · Australia (1) · Austria (1) · Belgium (1) · Cameroon (1)
Claude Labrie, M.D., Ph.D. (3) · David F Archer, MD (3) · Norbert Gleicher, MD (3) · Rosalind Ramsey-Goldman (3) · Catherine Jankowski, PhD (2) · David Barad, MD, MS (2) · David F Archer, M.D. (2) · Fernand Labrie, MD, PhD (2) · Leonello Cusan, MD, PhD (2) · AbdelGany M Hassan (1) · Allison M Quick, MD (1) · Alvaro Morales, MD FRCSC (1) · Anne Kenny, MD (1)
PMID 26972555, PMID 25968836, PMID 15536111, PMID 18634158, PMID 24796766, PMID 25734980, PMID 26291918, PMID 26517756, PMID 26597311, PMID 26634942, PMID 26731686, PMID 15361396, PMID 15529389, PMID 16735495, PMID 16997936, PMID 17665393, PMID 18071895, PMID 18359622, PMID 18598765, PMID 18812486, PMID 19424093, PMID 19436225, PMID 19436226, PMID 19811650, PMID 19854713, PMID 20191499, PMID 20459349, PMID 20638339, PMID 20729538, PMID 20863330, PMID 21244215, PMID 21632810, PMID 22835219, PMID 23084789, PMID 23144466, PMID 23212832, PMID 23562364, PMID 23664458, PMID 23744513, PMID 23954500, PMID 24004296, PMID 24774442, PMID 24932478, PMID 24986712, PMID 25129340, PMID 25296654, PMID 25395742, PMID 25510701, PMID 25511551, PMID 25771041
K23RR016191 (2), 1IK2CX001397-01A2 (1), I01CX002667 (1), M01RR000036 (1), P01AG014383 (1), P01HL158507 (1), P30CA015083 (1), P30CA022453 (1), P30CA069533 (1), P30DK056341 (1), P60AG013629 (1), P60DK020579 (1), R01AG020076 (1), R01AG053489 (1), R01AR077924 (1)